MASSDEVICE ON CALL — Medical device industry giant Medtronic (NYSE:MDT) is temporarily giving up on its pursuit of erectile dysfunction-treating peripheral stenting, the company told reporters.
Disappointing enrollment experiences led Medtronic to suspend its Impasse trial, an angiography study of pelvic anatomy as associated with erectile dysfunction, which was intended to include 350 patients.
"Due to the diagnostic screening challenges encountered during the enrollment phase of the ZEN trial, we decided after a great deal of consideration and consultation to suspend our clinical program for vasculogenic erectile dysfunction," Medtronic corporate communications director Joseph McGrath told Heartwire. "Appropriate patient selection proved more difficult than anticipated."
That’s bad news for the clutch of erectile dysfunction patients who have failed drug therapies. Preliminary results from the the older ZEN study had found strong and lasting effects of therapy with Medtronic’s drug-eluting pudendal stent in treatment of ED.
The 1st-in-man ZEN study dissolved after enrolling only 30 of more than 380 screened patients, due to selection issues that left researchers struggling to find participants.
"For us to have a screened failure rate of 92% means that we’re missing the appropriate population," ZEN investigator Dr. Krishna Rocha-Singh told Heartwire.
Nationwide ambivalence about healthcare reform
A set of essays from leading legal experts, economists and healthcare scholars revealed deep-seated ambivalence about the implications of the Supreme Court’s decision on the Affordable Care Act and what should be done about the state of healthcare in the U.S.
Mesh-covered stents best DES and BMS for restoring blood flow
Heart attack patients undergoing angioplasty experienced more heart tissue blood flow restoration when treated with next-generation mesh covered stents when compared to either drug-eluting or bare metal stents, according to the results of the Master trial.
Less imaging may mean more hospital time, study says
A preliminary study finding a drop in imaging use and simultaneous increase in length of hospital stays has some wondering whether the 2 are related.
Knee replacement extra hard on obese patients
Obese patients are more likely to suffer infections and other complications following knee replacement surgery and have a greater risk of needing follow-up surgery, according to a new study.